Logo of 4Dmedical (ASX:4DX)Latest 4Dmedical (ASX:4DX) News

Page 1
Page 1 of 7

4DMedical attributes sharp share price fall to increased short interest

4DMedical has denied holding undisclosed information that could explain a sharp sell-off in its shares, after ASX queried a fall from $3.28 to $2.41. The company said it believes increased short interest was responsible and confirmed compliance with continuous disclosure rules.
Victor Sage
2 Nov 2026

Market Wrap - Week 44 (26 Oct -> 30 Oct) 2026

Explorers led the strongest gains, while biotech, payments and gold producers suffered the biggest falls. Takeover bids, project funding and trial results drove sharp moves across the market.

Resources stayed busy, but investors punished companies with weak cash positions, delayed approvals or disappointing operating updates.
Logan Eniac
31 Oct 2026

4DMedical hits record scan volumes as global site count reaches 724

4DMedical reported a record first quarter, with scan volumes up 61% to 119,672 and unaudited operating revenue rising 66% to $2.3 million. New contracts across the US, Germany and Australia broaden the commercial story, while $242.8 million in cash gives the company room to keep investing.
Victor Sage
28 Oct 2026

Market Wrap - Week 39 (21 Sept -> 25 Sept) 2026

Small-cap resources led the week’s biggest moves, but sharp falls in Bounty Oil and Nyrada showed how quickly investors can sell when funding and deal terms remain uncertain.
Gold, copper, rare earths and takeover activity supplied the strongest gains, while several companies still need more cash before they can deliver their plans.
Logan Eniac
26 Sept 2026

4DMedical posts commercial growth but auditor qualifies FY26 report over asset values

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.
Victor Sage
24 Sept 2026

Market Wrap - Week 35 (24 Aug -> 28 Aug) 2026

Artificial intelligence stocks led the week, while miners and established companies delivered a broad run of stronger profits and dividends.
Large price gaps also showed that good company news did not always produce lasting buying.
Logan Eniac
29 Aug 2026

Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026

Healthcare shares split sharply this week, with Biome Australia rising while Nanosonics, Epiminder and Saluda Medical fell heavily.
Profits, trial progress and new approvals competed with cash needs, debt concerns and weaker investor confidence.
Logan Eniac
29 Aug 2026

4DMedical Accelerates CT:VQ™ Market Rollout with $3B US Opportunity and European Expansion

4DMedical’s CT:VQ™ lung imaging technology secured FDA clearance and CMS reimbursement, driving rapid adoption in top US medical centres and expanding its addressable market to $3 billion with new clinical programs and European contracts.
Ada Torres
28 Aug 2026

Market Wrap - Week 31 (27 July -> 31 July) 2026

Small-cap shares produced the week’s biggest moves, led by Xenitra’s 60% surge and Carnaby Resources’ takeover jump.
Mining news dominated, but sharp falls in Lotus Resources and several funded developers showed that new capital can still unsettle investors.
Logan Eniac
1 Aug 2026

Healthcare Wrap - Week 31 (27 July -> 31 July) 2026

Xenitra led the healthcare board after a three-year Chinese pharmaceutical deal, while Artrya and InteliCare delivered the week’s biggest contrasting moves. Across the sector, companies raised cash, won regulatory support and pushed deeper into US hospitals and clinics.
Logan Eniac
1 Aug 2026

4DMedical Expands US Footprint with SimonMed Deal and Posts 23% Revenue Growth

4DMedical has secured a pivotal three-year contract with SimonMed Imaging to deploy its CT:VQ™ lung imaging technology across over 170 US outpatient centres, while FY26 revenue rose 23% to $7.2 million on record scan volumes and global expansion.
Ada Torres
31 July 2026

Market Wrap - Week 26 (22 June -> 26 June) 2026

Big moves came from small and mid-cap names tied to drilling, project studies and fresh funding. Healthcare, mining and takeover stocks all had a busy week, but not every strong announcement held its gains.
Logan Eniac
27 June 2026